EP416 - ECE_1411 - Risk of incident chronic obstructive pulmonary disease in type 2 diabetes treated with SGLT2 inhibitors or GLP-1 receptor agonists vs DPP-4 inhibitors: a Real-World Cohort Study
SGLT2is and GLP-1 RAs were associated with a significantly lower risk of incident COPD compared with DPP4is in patients with T2D, which supports the potential respiratory-protective pleiotropic effects of these agents and may inform treatment selection for patients with T2D at risk for chronic lung disease.